Proteomics Market Trends

Proteomics Market Trends

Precision medicine, also commonly referred to as personalized medicine, is one of the most promising approaches to tackling diseases that have thus far eluded effective treatments or cures. As more diagnostic and analytical techniques are incorporated into medical practice, the demand for personalized medicine is increasing. Furthermore, the high sensitivity and accuracy of mass spectrometric analysis of proteins is suited for the incorporation of proteomics into personalized medicine, thereby supplementing the market size.
 

Moreover, the increasing number of patients suffering from chronic conditions such as cardiovascular diseases (CVDs), CKD, Cancer, neurodegenerative diseases, and rare genetic conditions is another factor contributing the market growth. The Agency for Healthcare Research and Quality adds that the direct economic impact of cancer is around $80 billion per year – loss of productivity, wages, and caregiver needs sap billions more from the economy. Precision medicine is an emerging approach for such disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Genetic testing is getting quicker and cheaper, offering researchers the opportunity to collect larger volumes of data from more diverse patient groups. By combining this data with clinical, pharmaceutical, and socioeconomic information, and then applying analytics to these integrated datasets, researchers and providers can observe patterns in the effectiveness of particular treatments and identify the genetic variations that may be correlated with success or failure. Thus, owing to the increasing prevalence of chronic diseases, the demand for personalized medicines increases that will result in a positive impact on the industry statistics.